News, prices and data come from third-party providers and may be delayed, incomplete, or inaccurate; they are only as reliable as those providers. AI-generated summaries, briefings and analysis can make mistakes, so please verify anything important independently. Everything here is general information only, not investment, financial, tax, or legal advice, and not a recommendation to buy or sell.
Civil Society Organizations Call for Revision of India's Essential Medicines List | Asgard News
Civil Society Organizations Call for Revision of India's Essential Medicines List
Updated 1d ago
67%Covered by 2 sources
First reported Jul 4, 2026·Latest coverage Jul 6, 2026
Advocates for NLEM ModernizationConsiderations for NLEM Revision
Was this helpful?
What everyone agrees on
Civil society organizations in India are demanding a revision of the National List of Essential Medicines (NLEM), which was last updated in 2022 and contains 384 medicines.
They are calling for a transparent, time-bound, and conflict-of-interest-free process to update the NLEM, noting that the WHO Model List of Essential Medicines has been revised in 2023 and 2025 and now includes 523 medicines.
Where perspectives diverge
Asgard's AI interpretation of the coverage, not the outlets' own words. Quotes marked verbatim appear word-for-word in the cited outlet's article.
Advocates for NLEM Modernization
Health groups are strongly advocating for an immediate update to India's National List of Essential Medicines (NLEM), arguing that the current list, last revised in 2022, is outdated compared to international standards. They emphasize the need to incorporate newer, essential medicines to improve public health outcomes and ensure comprehensive patient access.
Key arguments (3)
India's NLEM is outdated, last revised in 2022.
The WHO Model List has been updated twice since 2022 and now includes significantly more medicines (523 vs 384).
An update is necessary to ensure access to a comprehensive range of essential treatments for the Indian population.
✦ AI synthesisNo attributed verbatim quote met our verification bar - this framing is Asgard's reading of the coverage.
While acknowledging the calls for an update, the process of revising the National List of Essential Medicines (NLEM) involves complex considerations including cost-effectiveness, public health priorities, and resource allocation. The existing list, established in 2022, reflects a prior assessment of India's specific healthcare needs and economic realities, suggesting that revisions require careful deliberation beyond simply matching international lists.
Key arguments (3)
Revising the NLEM is a complex process requiring thorough evaluation of new medicines for efficacy and safety.
The 2022 list was based on specific national health priorities and resource constraints at the time of its formulation.
Adding a large number of new medicines could have significant cost implications for the healthcare system and patients, requiring careful financial planning.
✦ AI synthesisNo attributed verbatim quote met our verification bar - this framing is Asgard's reading of the coverage.